Vaccine works against hepatitis C in animals, study shows

08/3/2011 | Reuters

Tests on mice and monkeys showed that an experimental vaccine, made of viruslike particles, stimulated neutralizing antibodies to fight off multiple variants of hepatitis C virus, French scientists reported in Science Translational Medicine. Epixis CEO Charlotte Dalba said she expects the company to begin testing the vaccine in humans next year, provided it has enough funding. The French startup holds commercial rights to the vaccine.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA